Skip to main content
Resources

Patient education

Explore resources to support your patients’ journey in considering, preparing for, and living with Enterra® Therapy.

Understanding gastroparesis

Gastroparesis discussion guide

File type: PDF

This guide will provide an overview of gastroparesis, common tests used for diagnosis and treatment with Enterra® Therapy as well as patient and referral resources.

Download discussion guide
Challenge of Gastroparesis Brochure cover

The challenge of gastroparesis brochure

File type: PDF

Patient brochure that provides an overview of gastroparesis, as well as possible treatment options.

Download patient brochure
Español

Introduction to Enterra Therapy

A 3-minute video explaining gastroparesis and Enterra Therapy to patients.

Watch now

Gastroparesis pamphlet

File type: PDF

An overview about gastroparesis, causes, common tests for diagnosis, and treatment options, including Enterra® Therapy.

Download pamphlet
Patient Symptom Tracker thumbnail

Patient symptom tracker

File type: PDF

A log to help your patients record the severity and frequency of their gastroparesis symptoms.

Download symptom tracker
Nausea Vomiting Diary thumbnail

Symptom diary

File type: PDF

A tool to help your patients track the number of hours they experience nausea and vomiting each day.

Download symptom diary

Nutrition recommendations

File type: PDF

A patient resource for nutrition tips and recommendations.

Download brochure

Patient stories

NEXT: Media kit

MKT-D-0006, Rev L

IMPORTANT SAFETY INFORMATION

Enterra Therapy for treatment of chronic, resistant to medication nausea and vomiting associated with gastroparesis caused by diabetes or an unknown origin in patients aged 18 to 70 years: patients should always discuss potential risks and benefits of the device with their physician.

HUMANITARIAN DEVICE

Authorized by Federal law for use in the treatment of chronic intractable (drug refractory) nausea and vomiting secondary to gastroparesis of diabetic or idiopathic etiology in patients aged 18 to 70 years. The effectiveness of this device for this use has not been demonstrated. What does this mean?